Drug-drug interaction study of ciprofol and sodium divalproex: Pharmacokinetics, pharmacodynamics, and safety in healthy Chinese subjects

被引：4
作者：
Yang, Dandan [1 ]
Zhang, Wei [1 ]
Ruan, Zourong [1 ]
Jiang, Bo [1 ]
Huang, Siqi [2 ]
Wang, Jiaying [1 ]
Zhao, Pengfei [1 ]
Hu, Mengyue [3 ]
Yan, Min [2 ]
Lou, Honggang [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Ctr Clin Pharmacol, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Dept Anesthesiol, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Sichuan Haisco Pharmaceut Co Ltd, Chengdu, Peoples R China
来源：
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2023年 / 16卷 / 10期
关键词：
GENERAL-ANESTHESIA; VALPROIC ACID; PROPOFOL; INDUCTION; INJECTION; EFFICACY; PAIN; DERIVATIVES; MULTICENTER; PREVENTION;
D O I：
10.1111/cts.13605
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Ciprofol (also known as HSK3486) is a promising intravenous anesthetic candidate derived from propofol and independently developed by Haisco Pharmaceutical Group Co., Ltd. (Chengdu, China). Compared with propofol, ciprofol has the potential to reduce the dose required and the associated risks. Ciprofol is extensively metabolized in vivo, and its interaction with other concurrently administered drugs during clinical application is worthy of attention. Therefore, an open-label, two-stage sequential study was performed in healthy subjects who received either a single administration of ciprofol injection or ciprofol injection after oral administration of sodium divalproex. The aim of the study was to evaluate the effects of sodium divalproex on ciprofol with respect to pharmacokinetics, pharmacodynamics, and safety, thus providing a basis for the rational clinical use of ciprofol and sodium divalproex.
引用
收藏
页码：1972 / 1981
页数：10
相关论文
共 50 条
  • [11] Pharmacokinetics-Pharmacodynamics Modeling for Evaluating Drug-Drug Interactions in Polypharmacy: Development and Challenges
    Zhao, Di
    Huang, Ping
    Yu, Li
    He, Yu
    [J]. CLINICAL PHARMACOKINETICS, 2024, 63 (07) : 919 - 944
  • [12] Impact on Abiraterone Pharmacokinetics and Safety: Open-Label Drug-Drug Interaction Studies with Ketoconazole and Rifampicin
    Bernard, Apexa
    Vaccaro, Nicole
    Acharya, Milin
    Jiao, James
    Monbaliu, Johan
    De Vries, Ronald
    Stieltjes, Hans
    Yu, Margaret
    Tran, Namphuong
    Chien, Caly
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (01): : 63 - 73
  • [13] Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions
    Wiczling, Pawel
    Bieda, Krzysztof
    Przybylowski, Krzysztof
    Hartmann-Sobczynska, Roma
    Borsuk, Agnieszka
    Matysiak, Jan
    Kokot, Zenon J.
    Sobczynski, Pawel
    Grzeskowiak, Edmund
    Bienert, Agnieszka
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (05) : 252 - 263
  • [14] Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study
    Tachibana, Masaya
    Yamamura, Naotoshi
    Atiee, George J.
    Hsu, Ching
    Warren, Vance
    He, Ling
    Dishy, Victor
    Zahir, Hamim
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (10) : 2317 - 2324
  • [15] Drug-drug interaction study of imatinib and voriconazole in vitro and in vivo
    Lin, Qianmeng
    Xie, Saili
    Qiu, Xiangjun
    Chen, Jingjing
    Xu, Ren-Ai
    [J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 1021 - 1027
  • [16] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
    Luo, Zhu
    Wang, Jie
    Niu, Zhuolu
    Hu, Cuili
    Chintala, Madhu
    Luo, Xinchao
    Lee, Tsung-, I
    Plotnikov, Alexei N.
    Zannikos, Peter
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1503 - 1514
  • [17] Evaluation of the Potential for Pharmacokinetic Drug-Drug Interaction Between Armodafinil and Carbamazepine in Healthy Adults
    Darwish, Mona
    Bond, Mary
    Yang, Ronghua
    Hellriegel, Edward T.
    Robertson, Philmore, Jr.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (02) : 325 - 337
  • [18] Evaluation of Potential Pharmacokinetic Drug-Drug Interaction between Armodafinil and Aripiprazole in Healthy Adults
    Darwish, M.
    Bond, M.
    Yang, R.
    Hellriegel, E. T.
    Robertson, P., Jr.
    [J]. PHARMACOPSYCHIATRY, 2015, 48 (4-5) : 170 - 175
  • [19] Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia
    Favie, Laurent M. A.
    Groenendaal, Floris
    van den Broek, Marcel P. H.
    Rademaker, Carin M. A.
    de Haan, Timo R.
    van Straaten, Henrica L. M.
    Dijk, Peter H.
    van Heijst, Arno
    Simons, Sinno H. P.
    Dijkman, Koen P.
    Rijken, Monique
    Zonnenberg, Inge A.
    Cools, Filip
    Zecic, Alexandra
    van der Lee, Johanna H.
    Nuytemans, Debbie H. G. M.
    van Bel, Frank
    Egberts, Toine C. G.
    Huitema, Alwin D. R.
    Brouwer, Mieke J.
    Mulder-de Tollenaer, S. M.
    Jebbink-Akkerman, L. J. M. Groot
    Liem, Djien
    Steiner, Katerina
    Dudink, Jeroen
    de Jonge, Rogier C. J.
    Bos, Annelies A.
    Sonnaert, Michel
    Camfferman, Fleur Anne
    [J]. NEONATOLOGY, 2019, 116 (02) : 154 - 162
  • [20] Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg, a pegfilgrastim biosimilar in healthy subjects
    Roth, Karsten
    Lehnick, Dirk
    Wessels, Hendrik
    Hoefler, Josef
    Gastl, Barbara
    Jankowsky, Ruediger
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (05):
12345